Relacorilant Plus Nab-Paclitaxel Extends Survival in Women with Recurrent, Platinum-resistant Ovarian CancerGlobeNewsWire • 03/30/22
Corcept (CORT) Up 5.8% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/17/22
Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/16/22
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2021 Audited Financial Results and Provides Corporate UpdateGlobeNewsWire • 02/15/22
Corcept Therapeutics to Announce Fourth Quarter and Full-year 2021 Financial Results, Provide Corporate Update and Host Conference CallGlobeNewsWire • 02/08/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORTPRNewsWire • 01/28/22
Shareholder Alert: Robbins LLP Is Investigating the Officers and Directors of Corcept Therapeutics Incorporated (CORT)Business Wire • 01/25/22
Wall Street Analysts See a 26% Upside in Corcept (CORT): Can the Stock Really Move This High?Zacks Investment Research • 01/06/22
Corcept Therapeutics Announces Final Results of Previously Announced Tender OfferGlobeNewsWire • 12/20/21
CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics Inc. on Behalf of Corcept Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 12/15/21
Corcept Therapeutics Announces Extension of Previously Announced Tender OfferGlobeNewsWire • 12/08/21
Corcept Therapeutics Incorporated (CORT) CEO Dr. Joseph Belanoff on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21